| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$11 |
Change in substantial holding
|
26 Feb 2026 5:07PM |
$0.003 |
$0.002 |
fallen by
20%
|
|
| Iron Bear Resources Ltd (IBR) ORDINARY FULLY PAID |
Materials |
$58 |
Notification regarding unquoted securities - IBR
|
26 Feb 2026 5:05PM |
$0.047 |
$0.052 |
risen by
10.64%
|
|
| Nanosonics Limited (NAN) ORDINARY FULLY PAID |
Health Care |
$1,123 |
Becoming a substantial holder
|
26 Feb 2026 5:04PM |
$3.250 |
$3.700 |
risen by
13.85%
|
|
| Orbital Corporation Limited (OEC) ORDINARY FULLY PAID |
Industrials |
$36 |
Half Yearly Report and Accounts
|
26 Feb 2026 5:01PM |
$0.110 |
$0.200 |
risen by
81.82%
|
|
OEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a loss of $1,496,000 for the half-year ended 31 December 2025.
- Revenue from continuing operations was $4,892,000.
- Raised $3 million from equity placement for engine development.
- Remains debt-free with undrawn $2 million standby loan.
- Focus on expanding customer base and leveraging technology.
- Entered financing arrangement with Radium Capital for R&D.
- Advancing development of larger engine platforms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$341 |
Letter to Shareholders
|
26 Feb 2026 5:00PM |
$0.140 |
$0.150 |
risen by
7.14%
|
|
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$8 |
Half Yearly Report and Accounts
|
26 Feb 2026 5:00PM |
$0.003 |
$0.003 |
fallen by
0%
|
|
BIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Biotron Limited reported a loss of $920,969 for the half-year ended 31 December 2025.
- The company acquired Sedarex Limited, issuing 500,000,000 ordinary shares as part of the transaction.
- Biotron completed a rights issue and raised $1,523,860, including a shortfall allocation.
- The company focused on advancing its lead HBV drug, BIT-HBV001, which showed promising results in preclinical studies.
- Dr. Paul Kasian was appointed as a Non-Executive Director on 23 December 2025.
- Cash and cash equivalents increased to $1,642,799 as of 31 December 2025.
- Biotron continued its collaboration with US-based C14 Consulting Group for commercialization activities.
- The acquisition of Sedarex includes contingent consideration based on achieving certain milestones related to its SedRx general anaesthetic product.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$736 |
Becoming a substantial holder
|
26 Feb 2026 4:58PM |
$2.070 |
$1.980 |
fallen by
4.35%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,952 |
Change in substantial holding from MUFG
|
26 Feb 2026 4:56PM |
$19.400 |
$19.280 |
fallen by
0.62%
|
|
| Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$30 |
Appendix 4D and Interim Financial Report 31 Dec 2025
|
26 Feb 2026 4:55PM |
$0.013 |
$0.011 |
fallen by
15.38%
|
|
DUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dubber Corporation Limited reported a revenue of $18,698,469 for the period ending 31 December 2025, down from $20,521,713 in the previous year.
- Direct costs decreased to $5,634,317 from $6,520,178, resulting in revenue less direct costs of $13,064,152.
- The company reported a net loss before income tax of $4,449,380, down from $11,546,353 in 2024.
- Total comprehensive loss attributable to owners was $4,219,493 compared to $11,777,310 in the previous year.
- The basic and diluted loss per share reduced to 0.16 cents from 0.88 cents.
- Cash and cash equivalents stood at $7,341,439 as of 31 December 2025, compared to $10,863,888 on 30 June 2025.
- Net assets were $11,177,647, a decrease from $13,921,027.
- Issued capital increased to $355,997,315 from $353,232,255, with a total of 2,701,572,524 ordinary shares fully paid at the end of the period.
- The report includes a statement of changes in equity, noting significant transactions with directors involving share subscriptions and share-based payments.
- Directors expressed confidence in the company's ability to meet its debts as they fall due for a period of at least 12 months following the report's issuance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$9 |
1H FY26 financial results investor presentation
|
26 Feb 2026 4:54PM |
$0.125 |
$0.105 |
fallen by
16%
|
|
AVD - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth and improved operating efficiencies.
- Significant financial achievements in 1H FY26.
- Robust increase in revenue driven by organic growth and strategic acquisitions.
- Focus on enhancing service offerings and expanding market presence.
- Continued investments in technology and infrastructure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$9 |
1H FY26 financials reports improving operating performance
|
26 Feb 2026 4:53PM |
$0.125 |
$0.105 |
fallen by
16%
|
|
AVD - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue increased by 11% to $101.5 million.
- Statutory loss after tax was $16.5 million due to a $15 million non-cash impairment.
- Adjusted EBITDA of $7.1 million achieved through strong revenue growth.
- Strong revenue performance in Queensland and New South Wales.
- Challenging conditions in Victoria due to unionized labor requirements.
- Economic challenges persist in New Zealand.
- Leadership changes include Dan Crowley's transition to Executive Director.
- Transformation initiatives expected to deliver benefits in H2 FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PTR Minerals Ltd (PTR) ORDINARY FULLY PAID |
Materials |
$41 |
Section 708A Notice - Share Issue
|
26 Feb 2026 4:49PM |
$0.220 |
$0.105 |
fallen by
52.27%
|
|
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$9 |
Half Yearly Report and Accounts
|
26 Feb 2026 4:48PM |
$0.125 |
$0.105 |
fallen by
16%
|
|
AVD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half-year was $101.5 million.
- The group incurred a net loss of $16.5 million after tax.
- A $15 million impairment was recognized in the Victorian business.
- Strong revenue growth was noted in Queensland and New South Wales.
- The group is undergoing a refinancing process to be completed in Q3 FY26.
- The company reported a working capital deficiency as of 31 December 2025.
- No dividends were declared for the half-year.
- The company focuses on traffic management services across several Australian states and New Zealand.
- The directors are confident in meeting future financial obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JB Hi-Fi Limited (JBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$8,331 |
Change in substantial holding
|
26 Feb 2026 4:47PM |
$81.940 |
$76.200 |
fallen by
7.01%
|
|
| Southern Palladium Limited (SPD) ORDINARY FULLY PAID |
Materials |
$244 |
Notice under Section 708A(5)(e) of the Corporations Act
|
26 Feb 2026 4:46PM |
$2.150 |
$1.940 |
fallen by
9.77%
|
|
| Telstra Group Limited (TLS) ORDINARY FULLY PAID |
Communication Services |
$60,456 |
Update - Notification of buy-back - TLS
|
26 Feb 2026 4:46PM |
$5.140 |
$5.380 |
risen by
4.67%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,213 |
Change in substantial holding
|
26 Feb 2026 4:46PM |
$4.680 |
$4.790 |
risen by
2.35%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$14,937 |
Change of Director's Interest Notice
|
26 Feb 2026 4:45PM |
$49.000 |
$44.440 |
fallen by
9.31%
|
|
| Jatcorp Limited (JAT) ORDINARY FULLY PAID |
Consumer Discretionary |
$16 |
Half Yearly Report and Accounts
|
26 Feb 2026 4:45PM |
$0.130 |
$0.145 |
risen by
11.54%
|
|
JAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 36% to $23.0 million.
- Gross profit rose by 48% to $6.9 million.
- Net loss after tax decreased to $2.4 million from $6.6 million.
- Expanded market presence in Southeast Asia and China.
- Entered strategic partnerships, including a distribution agreement in Vietnam.
- Enhanced manufacturing capabilities at the ANMA facility.
- Cash balance stood at approximately $3.0 million as of 31 December 2025.
- Raised $4.2 million through an entitlement offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$341 |
Appendix 4G and Corporate Governance Statement
|
26 Feb 2026 4:41PM |
$0.140 |
$0.150 |
risen by
7.14%
|
|
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$341 |
Annual Report
|
26 Feb 2026 4:41PM |
$0.140 |
$0.150 |
risen by
7.14%
|
|
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$341 |
Appendix 4E
|
26 Feb 2026 4:38PM |
$0.140 |
$0.150 |
risen by
7.14%
|
|
BRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations increased by 374% to US$1,887,155.
- Operating loss was US$21,706,821, a 10% improvement from the previous year.
- No dividends were paid or proposed for the year ended 31 December 2025.
- Net tangible assets per share improved to 1.33 US cents.
- An unqualified audit report was issued for the financial statements.
- Financial statements used Australian Accounting Standards.
- A significant unrealized foreign exchange gain was reported.
- Interest income decreased compared to the previous year.
- The report is for the financial year ending 31 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| De.mem Limited (DEM) ORDINARY FULLY PAID |
Utilities |
$29 |
Change in substantial holding
|
26 Feb 2026 4:34PM |
$0.100 |
$0.088 |
fallen by
12%
|
|
| PEXA Group Limited (PXA) ORDINARY FULLY PAID |
Real Estate |
$2,176 |
Ceasing to be a substantial holder
|
26 Feb 2026 4:33PM |
$14.310 |
$12.370 |
fallen by
13.56%
|
|
| Perpetual Limited (PPT) ORDINARY FULLY PAID |
Financials |
$1,891 |
Change in substantial holding for EVT
|
26 Feb 2026 4:33PM |
$18.580 |
$16.350 |
fallen by
12%
|
|
Call 1300 880 160
Start a chat
Schedule a call
